AzTrials
AzTrials

High Flow Nasal CanulaNCT07575776

Effect of High-Flow Nasal Oxygen on Laryngoscopic View

An observational study of High Flow Nasal Canula and Laryngoscopy, run by Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s..

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

This prospective, multicenter observational study aims to evaluate the effect of different flow rates of high-flow nasal oxygen (HFNO) on the quality of the laryngoscopic view during videolaryngoscopy in adult patients undergoing general anesthesia. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
HFNO flow 0, HFNO flow 40 and HFNO 60
Type of treatment
Medical device
How many people
150 participants
Where
No sites listed yet
Study dates
1 Sep 2026to 1 Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients undergoing elective surgical procedures requiring endotracheal intubation under general anesthesia.

Who may be able to join

  • Age ≥18 years
  • Scheduled for endotracheal intubation under general anesthesia
  • Use of videolaryngoscopy

Who cannot join

  • Anticipated difficult airway
  • Emergency intubation
  • Contraindications to HFNO
  • Inability to obtain adequate video recording

About this study

Official title: Effect of Different Flows Using High-Flow Nasal Oxygen (HFNO) on Laryngoscopic View Quality During Videolaryngoscopy

This prospective, multicenter observational study aims to evaluate the effect of different flow rates of high-flow nasal oxygen (HFNO) on the quality of the laryngoscopic view during videolaryngoscopy in adult patients undergoing general anesthesia. Each patient will serve as their own control, with repeated measurements obtained at three different HFNO flow settings (0, 40, and 60 L/min). The study will assess objective and subjective parameters of glottic visualization using standardized scoring systems.

Read the detailed description

Anaesthetic management Anaesthesia induction and airway management will be standardized as far as clinically feasible. Standard monitoring will be applied according to institutional practice. Preoxygenation will be performed using high-flow nasal oxygen (HFNO). General anaesthesia will be induced using standard intravenous agents, followed by administration of neuromuscular blockade to facilitate laryngoscopy. Mask ventilation will be performed as clinically indicated.

Videolaryngoscopy will be performed using a standardized device and blade type whenever possible. All procedures will be performed by anesthesiologists experienced in videolaryngoscopy.

Study procedure

After induction of anaesthesia and achievement of adequate conditions for laryngoscopy, videolaryngoscopy will be performed. During a single laryngoscopic sequence, images of the laryngeal view will be obtained under three predefined HFNO flow conditions:

  • 0 L/min
  • 40 L/min
  • 60 L/min At each flow level, once a stable laryngeal view will be achieved, a still image will be captured using the videolaryngoscope recording system. The laryngoscope position will be maintained as stable as possible during acquisition of all three images. No attempt at tracheal intubation will be made during image acquisition.

After completion of the image capture protocol, tracheal intubation will be performed according to standard clinical practice.

All images will be anonymized and stored for subsequent offline analysis. Image assessment Captured images will be evaluated offline by an independent anesthesiologist blinded to HFNO flow rates and patient identity. Where applicable, evaluation will be performed by more than one assessor to allow assessment of inter-rater agreement.

Each image will be assessed using predefined objective and subjective measures (Percentage of Glottic Opening, Likert scale).

Being tested
HFNO flow 0, HFNO flow 40, HFNO 60
Keywords
high flow nasal canula, thrive, difficult airway, airway management, anaesthesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HFNO flow 0Device

    Different flows will be applied to patients undergoing general anaesthesia during airway management. In this arm flow will be 0 l/min. During these flows images will be captured using videolaryngoscope.

  • HFNO flow 40Device

    Different flows will be applied to patients undergoing general anaesthesia during airway management. In this arm flow will 40 l/min. During these flows images will be captured using videolaryngoscope.

  • HFNO 60Device

    Different flows will be applied to patients undergoing general anaesthesia during airway management. In this arm flow will 60 l/min. During these flows images will be captured using videolaryngoscope.

Study groups in NCT07575776
Study groupRoleWhat they receive
Group HFNOAdult patients with HFNO support for airway management
Receives: Device: HFNO flow 0; Device: HFNO flow 40; Device: HFNO 60

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of view

    Percentage of glottic opening (POGO score) assessed from recorded videolaryngoscopic images.

    Measured: From induction of general anesthesia to completion of orotracheal intubation (not longer than 10 minutes).

Secondary outcomes (2)
  1. Cormack-Lehane classification

    Ordinal grading of glottic view using Cormack- Lehane classification.

    Measured: From induction of general anesthesia to completion of orotracheal intubation (not longer than 10 minutes).

  2. Subjective image quality (Likert scale)

    Subjective assessment of laryngoscopic image quality rated on a 5-point Likert scale (1 = very poor, 5 = excellent) by independent evaluators blinded to HFNO flow conditions

    Measured: From induction of general anesthesia to completion of orotracheal intubation (not longer than 10 minutes).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2026
  2. Study start1 Sep 2026 (estimated)
  3. Primary completion1 Sep 2027 (estimated)
  4. Study completion1 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07575776
Sponsor's protocol ID
HFNORCT
Status last verified
May 2026
First submitted
4 May 2026
Last updated
8 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of High Flow Nasal Canula and Laryngoscopy, run by Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s..

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 May 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of view (time frame: From induction of general anesthesia to completion of orotracheal intubation (not longer than 10 minutes).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in